
Charlotte Coe, a State Department IT specialist, has a urethral lesion from a vaginoplasty that, in Coe's own words, "feels like a constant papercut." The tissue bleeds when irritated. Sexual activity is painful. Sitting wrong reopens the wound. Coe described being "at near-constant risk for infection when it opens, which makes sexual activity of any kind painful and dangerous, and means I must be very mindful of my sitting position, underwear tightness, and my daily activities to avoid reopening or prolonging opening of the lesion."
The federal government's insurance plan paid for every bit of it.
Coe is one of three named class representatives in a lawsuit filed in D.C. federal court against the federal government, challenging the phaseout of taxpayer-funded "gender affirming care" coverage that began in 2026, with full elimination set for 2027. The amended complaint was filed November 2, followed by a motion for a preliminary injunction on November 4. The plaintiffs aren't conservative critics. They're federal employees who underwent the procedures the government covered and the medical establishment championed — and they're now cataloging the damage in sworn declarations, as reported by Just The News.
The lawsuit leans on Title VII of the Civil Rights Act and the 2020 Supreme Court Bostock precedent on employment discrimination. The legal argument is that cutting off coverage constitutes sex discrimination. But the declarations attached to the filings tell a different story than the legal theory — they read less like a civil rights complaint and more like a injury report.
Vanessa Voe, identified as a War Department researcher who spent eight years on hormone replacement therapy and six years undergoing surgical procedures, described what happens during gaps in hormone access. "[D]uring these periods I grew unwanted hair, had greasier skin and hair," Voe stated, adding that "my body suffers irreversible harm" and the changes would cause "my friends and colleagues will perceive me as a different person." Voe warned the disruption could force a "withdraw from my marriage."
A third plaintiff, Christine F., whose last name was withheld, underwent a colovaginoplasty — a procedure estimated at $100,000. The complaint also references breast augmentation, breast augmentation "revision," testicle removal, facial feminization surgery, and electrolysis. This is not a single procedure being debated in the abstract. This is a cascade of surgeries, each one creating a dependency on the next, each one making reversal less possible.
The motion for preliminary injunction argues that the plaintiffs "require ongoing hormone therapy because their bodies no longer produce the hormones they need" and will "ration their prescribed hormones," likely facing "debilitating symptoms, such as intrusive thoughts, mental and emotional upheaval, and withdrawal." The complaint itself compares the coverage cutoff to "denying continuing insulin treatment for someone with diabetes."
That analogy is doing a lot of heavy lifting. Diabetics didn't choose a surgical intervention that destroyed the organ producing their insulin. The plaintiffs' own declarations describe bodies that now depend on external hormones precisely because the procedures removed the organs that produced them naturally. The insulin comparison isn't a legal argument — it's an admission that the treatment created a permanent medical dependency.
The broader legal landscape has not been kind to the "gender affirming" framework. The Supreme Court upheld Tennessee's ban on these procedures for minors. It upheld West Virginia's sports participation ban. Chief Justice Roberts himself has pushed back on gender ideology language in court proceedings. The World Professional Association for Transgender Health, once treated as the unassailable authority on these protocols, has faced increasing scrutiny from organizations like the Society for Evidence-Based Gender Medicine. The medical consensus the plaintiffs are relying on is the same consensus that's been unraveling in courtrooms and medical journals for two years running.
Meanwhile, the case of Fox Varian — a plaintiff in a separate matter who won a $2 million jury award — and the advocacy of detransitioner Maddie Durbin through Independent Women have shifted the public conversation. The people with firsthand experience are increasingly the ones saying the system failed them, not the ones defending it.
The plaintiffs want the court to force the government to keep paying for the procedures and the lifetime of hormones those procedures made necessary. Their own filings describe labial and vulvar tissue that resembles "scrotal anatomy," bone density loss, decreased muscle strength, brain fog, acne, and irritability as consequences of the care they received and now cannot stop receiving.
The government told its employees this care was safe. It covered the surgeries, the hormones, the revisions. Now the employees who trusted that coverage are in federal court — not to say thank you, but to describe, under oath, what was done to their bodies.
The declarations are public record. Document 26.6. Document 26.7. Document 26.12.



